We’re trying something new! Welcome to the first Endpoints Slack Interview, where we chat with interesting people in biotech, pharma, venture capital and science about what they’re working on, what they think and who they are.
Our first conversation is with Josh Wolfe, cofounder and managing partner of Lux Capital. He logged in to our top secret Slack channel last week, and the conversation has been very minimally edited for readability.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters